Clinical trial
A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and…
NCT00148785 · Emory University, Other · Completed
Key facts
| NCT number | NCT00148785 |
|---|---|
| Title | A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir |
| Official title | Pharmacokinetics of an Indinavir, Ritonavir and Amprenavir Regimen in HIV-Infected Individuals: A Pilot Study |
| Lead sponsor | Emory University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Indinavir/Ritonavir/Fosamprenavir |
| Enrollment | 15 |
| Start date | Jul 1, 2005 |
| Completion | Jan 1, 2007 |
| First posted | Sep 8, 2005 |
| Last update posted | Nov 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: